Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0009402 (colorectal cancer)
 53,228 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

There is no ideal animal model for the study of human pathologies such as IBD or CRC. For the last decade, genetically engineered animal models have been incorporated to models induced by exogenous agents. Experimental models of IBD reproduce heterogeneous intestinal inflammatory conditions, as it occurs in the human being, whereas CRC models imitate those mutations found in man although with different phenotypic repercussions. In both cases, these experimental systems are influenced by genetics and the environment. Today, animal models represent valued, complex, and complete bioassays for the study of new therapeutic strategies in IBD (IL-10, anti-IL-12, probiotics) and protective agents in CRC (n-3 fatty acids, NSAIDS, and COX-2 inhibitors).
 ...
PMID:[In vivo experimental models of inflammatory bowel disease and colorectal cancer]. 1741 34

The cyclooxygenase (COX) is a key enzyme in the conversion of arachidonic acid to prostaglandins. COX-1 is constitutively expressed and is a critical housekeeping gene, whereas COX-2 is rapidly upregulated by growth factors and cytokines and thus responsible for inflammation. COX-2 is frequently overexpressed in colonic adenoma and carcinoma. Specific inhibitors of COX-2 have been shown to induce apoptosis in tumor cells and to inhibit tumor growth in animal models and in humans. Long-standing IBD patients have increased risk of developing colorectal cancer compared to general population. IBD-associated colorectal carcinogenesis is probably promoted by chronic inflammation and closely related to COX-2. In a recent study, powerful chemopreventive ability of selective COX-2 inhibitor was observed in colitis-related colon carcinogenesis in mouse model. But it was reported that even selective COX inhibitors aggravated the DSS-induced colonic inflammation. It is assumed that endogenous PGs are involved in the mucosal defense against DSS-induced colonic ulcerations which are produced by COX-1 at early phase and by COX-2 at late phase. Long-term use of COX-2 inhibitors for the chemoprevention of colitic cancer is needed to define their mechanism of action, that reduce side effects and have specific tumor target.
 ...
PMID:[COX-2 inhibitors in inflammatory bowel disease: friends or foes?]. 1815 71

The gastrointestinal tract represents the most important extra pineal source of melatonin. Presence of melatonin (M) suggests that this hormone is somehow involved in digestive pathophysiology. Release of GI melatonin from serotonin-rich enterochromaffin EC cells of the GI mucosa suggest close antagonistic relationship with serotonin (S) and seem to be related to periodicity of food intake. Food deprivation resulted in an increase of tissue and plasma concentrations of M. Its also act as an autocrine and paracrine hormone affecting not only epithelium and immune system but also smooth muscle of the digestive tract. Low doses M improve gastrointestinal transit and affect MMC. M reinforce MMCs cyclic pattern but inhibits spiking bowel activity. Pharmacological doses of M delay gastric emptying via mechanisms that involve CCK2 and 5HT3 receptors. M released in response to lipid infusion exerts a modulatory influence that decreases the inhibitory effects of the ileal brake on gastric emptying. On isolated bowel S induces dose dependent increase in tone and reduction in amplitude of contraction which is affected by M. M reduced the tone but not amplitude or frequency of contraction. M is a promising therapeutic agent for IBS with activities independent of its effects on sleep, anxiety or depression. Since of its unique properties M could be considered for prevention or treatment of colorectal cancer, ulcerative colitis, gastric ulcers and irritable bowel syndrome.
 ...
PMID:Melatonin and serotonin effects on gastrointestinal motility. 1821 3

Dairy foods (DFs) contain complex ingredients that could affect different diseases. The control of lactose digestion phenotypically divides populations into those who can [lactase persistent (LP)] and those who cannot [lactase nonpersistent (LNP)] assimilate lactose. LNP subjects, however, can adapt to lactose intolerance through intestinal bacteria. The DF/LNP status interactions may function as disease risk modifiers. We evaluated the relationship between DF and LNP with colorectal, breast, prostate, ovarian, lung, and stomach cancer and inflammatory bowel diseases (IBD; Crohn's disease and ulcerative colitis). Yearly per capita DF consumption, LNP national prevalence, cancer mortality, and incidence of IBD were obtained from several sources. A negative binomial regression model was used to derive incremental risks. There were statistically significant (P <or= 0.05) increases in risk for colorectal and prostate cancer and ulcerative colitis with DFs and a statistically significant decreased risk for stomach cancer. There were trends (P<0.1) for lung and ovarian cancers and Crohn's disease. As LNP prevalence increased, stomach cancer risk increased, whereas risks of all other conditions decreased (P<0.01). In 3 cancers (prostate, ovarian, and breast), meta-analyses of case-based studies support ecological data. In colorectal cancer, on the contrary, meta-analyses of case-based studies suggest protection. The possible importance of distinguishing LNP/LP status in studies is discussed.
 ...
PMID:Impact of lactose containing foods and the genetics of lactase on diseases: an analytical review of population data. 1844 63

Gastrointestinal problems account for a significant proportion of general practitioners' workload, and gastrointestinal cancers, taken together, make up the largest group of malignancies. Approximately 10% of consultations in general practice in the UK are for gastrointestinal symptoms or problems, split roughly equally between the upper and lower gastrointestinal tract. Gastroenterology represents about 10% of the work of hospital specialists and the prescribing costs involved in the management of gastrointestinal disorders in general practice are around 14% of the drug budget. These disorders range from relatively minor and self limiting conditions such as acute gastritis and acute gastroenteritis, through the more significant, chronic digestive disorders such as gastro-oesophageal reflux disease (GORD), irritable bowel syndrome (IBS) and coeliac disease, to much more serious problems including inflammatory bowel disease (IBD) and upper gastrointestinal and colorectal cancer.
 ...
PMID:Primary care research and clinical practice: gastroenterology. 1894 Sep 46

Strict adherence to recommended surveillance intervals is important in ensuring timely access for patients awaiting endoscopy. This study aimed to characterise adherence rates to surveillance endoscopy guidelines. All surveillance procedures scheduled between January and December 2006 were reviewed. Surveillance procedures were classified as: a) Barrett's oesophagus, b) chronic IBD, c) prior adenomatous colorectal polyps and, d) prior surgical resection of colorectal cancer. 441 endoscopies were scheduled for surveillance of which 195 (44.2%) were scheduled at an inappropriate interval; all were scheduled prematurely. Of these, 50 of 133 (37.6%) Barrett's patients, 92 of 213 (43.2%) patients with prior colonic polyps, 36 of 48 (75.0%) patients with prior colonic malignancy and 17 of 47 (36.2%) patients for IBD surveillance were scheduled prematurely. Almost half of all surveillance procedures were scheduled inappropriately early. This 'over-surveillance' represents an unnecessary additional burden on the current endoscopic workload.
 ...
PMID:Assessment of adherence to published surveillance guidelines--opportunity to enhance efficiency of endoscopic practice. 1899 Sep 56

Functional abdominal disorders are predominantly diagnosed on the basis of a thorough history and clinical examination. It is a challenge to clinicians to define the adequate place of imaging studies in order to rule out relevant organic disease. In functional dyspepsia, oesphago-gastroduodensoscopy and abdominal ultrasound are widely used as first line studies. Although irritable bowel syndrome is mainly diagnosed on clinical grounds, in patients over 50 years of age colonoscopy is almost mandatory, taking into account the importance of screening for colorectal cancer. In constipation-dominant irritable bowel syndrome, a marker study to determine colonic transit time will be helpful to differentiate this disorder from true slow transit constipation. Chronic or recurrent abdominal pain often warrants abdominal CT scan. Select cases are referred for laparoscopy.
 ...
PMID:[Imaging studies in the diagnosis of functional abdominal disorders]. 1910 52

In patients with IBD, chronic colonic inflammation increases the risk of colorectal cancer, perhaps because inflammation predisposes these tissues to genomic instability. Carcinogenesis in the inflamed colon seems to follow a different sequence of genetic alterations than that observed in sporadic cancers in the uninflamed colon. In this Review, we focus on the genetic alterations in colitis-associated colorectal cancer that contribute to the acquisition of the essential hallmarks of cancer, and on how those alterations differ from sporadic colorectal cancers. Our intent is to provide a conceptual basis for categorizing carcinogenetic molecular abnormalities in IBD, and for understanding how cancer-preventive therapies might target reversal of acquired abnormalities in specific biochemical pathways.
 ...
PMID:Carcinogenesis in IBD: potential targets for the prevention of colorectal cancer. 1940 70

The normal microbiota and man form a superorganism, in which only 10% are human cells. The skin and mucous membranes support 10(14) living microbes, mainly at the end of the gastrointestinal tract, forming a 1.5-kg cell mass ecosystem mainly consisting of bacteria. Investigations of the intestinal microbiota have yielded an estimated biodiversity of 1200-16000 bacterial phylotypes. They are known to affect physiology, development of immune defense, colonization resistance and nutrition. Changes in microbial population can be associated with inflammatory bowel diseases, irritable bowel syndrome, colorectal cancer, obesity and type 2 diabetes.
 ...
PMID:[Intestinal microorganisms and their significance for health]. 1941 74

At DDW 2008 around 1000 abstracts on inflammatory bowel disease were presented. Our goal in this report is to summarize the most important new data on diagnosis, smoking and cancer related to IBD. MRI is emerging as a basic diagnostic tool in Crohn's disease. New data are accumulating demonstrating that smoking has a negative impact on natural history of CD even when treated in very specialized units, and with moderate tobacco use. When population-based studies are considered, colorectal cancer is not so a frequent complication as has been reported in referente centres. However, its incident does fully justify surveillance, although more and more data show that the key point to diminish the incidence of cancer is a good control of inflammation.
 ...
PMID:[Inflammatory bowel disease]. 1943 65


<< Previous 1 2 3 4 5 6 7 8 9 10 Next >>